Severe ME Day of Understanding and Remembrance: Aug. 8, 2017
Determined to paper the Internet with articles about ME, Jody Smith brings some additional focus to Severe Myalgic Encephalomyelitis Day of Understanding and Remembrance on Aug. 8, 2017 ...
Discuss the article on the Forums.

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies

Discussion in 'Other Health News and Research' started by Dolphin, Dec 8, 2014.

  1. Dolphin

    Dolphin Senior Member

    Messages:
    10,533
    Likes:
    27,372
    Probably a minority interest

    Free full text: http://www.trialsjournal.com/content/15/1/456

     
    Sasha, Simon, Valentijn and 3 others like this.
  2. Esther12

    Esther12 Senior Member

    Messages:
    8,239
    Likes:
    26,410
    Almost shouldn't need saying... lots of CFS research shows that it does.
     
    Dolphin, Sasha, Simon and 1 other person like this.
  3. Valentijn

    Valentijn The Diabolic Logic

    Messages:
    14,032
    Likes:
    43,315
    So if you can't blind the assessors, at least use objective indications for outcomes and adverse reactions :rolleyes:
     

See more popular forum discussions.

Share This Page